HL7 - Version 2.7.1


Segment CTI: Clinical Trial Identification (Studienidentifizierung)

Seq Description German Interpretation Length C.LEN Table r/o/c Rep# Item Data Structure Section
1 Sponsor Study ID Studien-ID des Sponsors


R
01011 EI 7.8.4.1
2 Study Phase Identifier ID der Studienphase

9999 C
01022 CWE 7.8.4.2
3 Study Scheduled Time Point Zeitmarke (relativer Zeitpunkt) im Studienprotokoll

9999 O
01055 CWE 7.8.4.3

Used within following Message Structures:

CCI_I22 Collaborative Care Information (11.6.2)
CCI_I22 Collaborative Care Information (11.6.2)
CCM_I21 Collaborative Care Message (11.5.1)
CCM_I21 Collaborative Care Message (11.5.1)
CCR_I16 Collaborative Care Referral (11.5.2)
CCR_I16 Collaborative Care Referral (11.5.2)
CCR_I16 Collaborative Care Referral (11.5.2)
CCU_I20 Collaborative Care Referral (11.5.6)
CCU_I20 Collaborative Care Referral (11.5.6)
CQU_I19 Collaborative Care Referral (11.6.1)
CQU_I19 Collaborative Care Referral (11.6.1)
OMG_O19 General Clinical Order Message (4.3.4)
OML_O21 Laboratory Order Message (4.3.6)
OML_O33 Laboratory Order - Multiple Order Per Specimen Mes (4.3.8)
OML_O35 Laboratory Order - Multiple Order Per Container of (4.3.10)
OML_O39 Specimen Shipment Centric Laboratory Order Message (4.3.12)
OPL_O37 Population/Location-Based Laboratory Order Message (4.3.16)
ORG_O20 General Clinical Order Acknowledgment Message (4.3.5)
ORU_R01 Observation Message (5.7.3.0)
OUL_R22 Observation Message (7.3.8)
OUL_R23 Observation Message (7.3.9)
OUL_R24 Observation Message (7.3.10)
RAS_O17 Pharmacy/Treatment Administration (4.A.11)
RDE_O11 Pharmacy/Treatment Refill Authorization Request (4.A.5)